Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Nov 12;287(6403):1413–1417. doi: 10.1136/bmj.287.6403.1413

Enalapril in the treatment of hypertension with renal artery stenosis.

G P Hodsman, J J Brown, A M Cumming, D L Davies, B W East, A F Lever, J J Morton, G D Murray, I Robertson, J I Robertson
PMCID: PMC1549614  PMID: 6315126

Abstract

The converting enzyme inhibitor enalapril, in single daily doses of 10-40 mg, was given to 20 hypertensive patients with renal artery stenosis. The blood pressure fall six hours after the first dose of enalapril was significantly related to the pretreatment plasma concentrations of active renin and angiotensin II and to the concurrent fall in angiotensin II. Blood pressure fell further with continued treatment; the long term fall was not significantly related to pretreatment plasma renin or angiotensin II concentrations. At three months, 24 hours after the last dose of enalapril, blood pressure, plasma angiotensin II, and converting enzyme activity remained low and active renin and angiotensin I high; six hours after dosing, angiotensin II had, however, fallen further. The rise in active renin during long term treatment was proportionally greater than the rise in angiotensin I; this probably reflects the fall in renin substrate that occurs with converting enzyme inhibition. Enalapril alone caused reduction in exchangeable sodium, with distinct increases in serum potassium, creatinine, and urea. Enalapril was well tolerated and controlled hypertension effectively long term; only two of the 20 patients required concomitant diuretic treatment.

Full text

PDF
1417

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldigier J. C., Plouin P. F., Guyene T. T., Thibonnier M., Corvol P., Menard J. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension. Am J Cardiol. 1982 Apr 21;49(6):1447–1452. doi: 10.1016/0002-9149(82)90359-9. [DOI] [PubMed] [Google Scholar]
  2. Anderson W. P., Korner P. I., Johnston C. I. Acute angiotensin II-mediated restoration of distal renal artery pressure in renal artery stenosis and its relationship to the development of sustained one-kidney hypertension in conscious dogs. Hypertension. 1979 May-Jun;1(3):292–298. doi: 10.1161/01.hyp.1.3.292. [DOI] [PubMed] [Google Scholar]
  3. Atkinson A. B., Brown J. J., Cumming A. M., Fraser R., Lever A. F., Leckie B. J., Morton J. J., Robertson J. I. Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) 1982 Mar 6;284(6317):689–693. doi: 10.1136/bmj.284.6317.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Atkinson A. B., Brown J. J., Cumming A. M., Fraser R., Lever A. F., Leckie B. J., Morton J. J., Robertson J. I., Davies D. L. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome. Am J Cardiol. 1982 Apr 21;49(6):1460–1466. doi: 10.1016/0002-9149(82)90361-7. [DOI] [PubMed] [Google Scholar]
  5. Atkinson A. B., Cumming A. M., Brown J. J., Fraser R., Leckie B., Lever A. F., Morton J. J., Robertson J. I. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Br J Clin Pharmacol. 1982 Jun;13(6):855–858. doi: 10.1111/j.1365-2125.1982.tb01878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bean B. L., Brown J. J., Casals-Stenzel J., Fraser R., Lever A. F., Millar J. A., Morton J. J., Petch B., Riegger A. J., Robertson J. I. The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Circ Res. 1979 Apr;44(4):452–458. doi: 10.1161/01.res.44.4.452. [DOI] [PubMed] [Google Scholar]
  7. Boddy K., King P. C., Tothill P., Strong J. A. Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors. Phys Med Biol. 1971 Apr;16(2):275–282. doi: 10.1088/0031-9155/16/2/310. [DOI] [PubMed] [Google Scholar]
  8. Brown J. J., Casals-Stenzel J., Cumming A. M., Davies D. L., Fraser R., Lever A. F., Morton J. J., Semple P. F., Tree M., Robertson J. I. Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension. 1979 May-Jun;1(3):159–179. doi: 10.1161/01.hyp.1.3.159. [DOI] [PubMed] [Google Scholar]
  9. Burkinshaw L., Morgan D. B., Silverton N. P., Thomas R. D. Total body nitrogen and its relation to body potassium and fat-free mass in healthy subjects. Clin Sci (Lond) 1981 Oct;61(4):457–462. doi: 10.1042/cs0610457. [DOI] [PubMed] [Google Scholar]
  10. Davies D. L., Robertson J. W. Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na. Metabolism. 1973 Feb;22(2):133–137. doi: 10.1016/0026-0495(73)90263-1. [DOI] [PubMed] [Google Scholar]
  11. Farrow P. R., Wilkinson R. Reversible renal failure during treatment with captopril. Br Med J. 1979 Jun 23;1(6179):1680–1680. doi: 10.1136/bmj.1.6179.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fraser R., Guest S., Young J. A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med. 1973 Sep;45(3):411–415. doi: 10.1042/cs0450411. [DOI] [PubMed] [Google Scholar]
  13. Hodsman G. P., Brown J. J., Davies D. L., Fraser R., Lever A. F., Morton J. J., Murray G. D., Robertson J. I. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis. Br Med J (Clin Res Ed) 1982 Dec 11;285(6356):1697–1699. doi: 10.1136/bmj.285.6356.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hodsman G. P., Isles C. G., Murray G. D., Usherwood T. P., Webb D. J., Robertson J. I. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) 1983 Mar 12;286(6368):832–834. doi: 10.1136/bmj.286.6368.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hodsman G. P., Robertson J. I. Captopril: five years on. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):851–852. doi: 10.1136/bmj.287.6396.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hollenberg N. K. Renal response to angiotensin-converting enzyme inhibition. Am J Cardiol. 1982 Apr 21;49(6):1425–1429. doi: 10.1016/0002-9149(82)90355-1. [DOI] [PubMed] [Google Scholar]
  17. Hricik D. E., Browning P. J., Kopelman R., Goorno W. E., Madias N. E., Dzau V. J. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983 Feb 17;308(7):373–376. doi: 10.1056/NEJM198302173080706. [DOI] [PubMed] [Google Scholar]
  18. Mackay A., Eadie A. S., Cumming A. M., Graham A. G., Adams F. G., Horton P. W. Assessment of total and divided renal plasma flow by 123I-hippuran renography. Kidney Int. 1981 Jan;19(1):49–57. doi: 10.1038/ki.1981.6. [DOI] [PubMed] [Google Scholar]
  20. Rasmussen S., Damkjaer Nielsen M., Giese J. Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays. Clin Sci (Lond) 1981 May;60(5):591–593. doi: 10.1042/cs0600591. [DOI] [PubMed] [Google Scholar]
  21. Rosei E. A., Brown J. J., Cumming A. M., Fraser R., Semple P. F., Lever A. F., Morton J. J., Robertson A. S., Robertson J. I., Tree M. Is the 'sodium index' a useful way of expressing clinical plasma renin, angiotensin and aldosterone values? Clin Endocrinol (Oxf) 1978 Feb;8(2):141–147. doi: 10.1111/j.1365-2265.1978.tb02162.x. [DOI] [PubMed] [Google Scholar]
  22. Silas J. H., Klenka Z., Solomon S. A., Bone J. M. Captopril induced reversible renal failure: a marker of renal artery stenosis affecting a solitary kidney. Br Med J (Clin Res Ed) 1983 May 28;286(6379):1702–1703. doi: 10.1136/bmj.286.6379.1702-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Staessen J., Bulpitt C., Fagard R., Lijnen P., Amery A. Long-term converting-enzyme inhibition as a guide to surgical curability of hypertension associated with renovascular disease. Am J Cardiol. 1983 May 1;51(8):1317–1322. doi: 10.1016/0002-9149(83)90305-3. [DOI] [PubMed] [Google Scholar]
  24. Waite M. A. Measurement of concentrations of angiotensin I in human blood by radioimmunoassay. Clin Sci. 1973 Jul;45(1):51–64. doi: 10.1042/cs0450051. [DOI] [PubMed] [Google Scholar]
  25. Wright B. M., Dore C. F. A random-zero sphygmomanometer. Lancet. 1970 Feb 14;1(7642):337–338. doi: 10.1016/s0140-6736(70)90709-9. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES